Celastrol inhibits lung infiltration in differential syndrome animal models by reducing TNF-α and ICAM-1 levels while preserving differentiation in ATRA-induced acute promyelocytic leukemia cells.

Celastrol inhibits lung infiltration in differential syndrome animal models by reducing TNF-α and ICAM-1 levels while preserving differentiation in ATRA-induced acute promyelocytic leukemia cells.

All-trans retinoic acid (ATRA) is a revolutionary agent for acute promyelocytic leukemia (APL) treatment via differentiation induction. However, ATRA treatment also increases cytokine, chemokine, and adhesive molecule (mainly ICAM-1) expression, which can cause clinical complications, including a se...

Full description

Bibliographic Details
Main Authors: Li-min Xu, Yue-juan Zheng, Ying Wang, Yang Yang, Fan-fan Cao, Bin Peng, Xiong-fei Xu, Hua-zhang An, Ao-xiang Zheng, Deng-hai Zhang, Georges Uzan, Yi-zhi Yu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4130635?pdf=render

Internet

http://europepmc.org/articles/PMC4130635?pdf=render

Similar Items